Concepedia

Nam Fung Kar

NF

3

Publications

125

Citations

3

H-Index

2015

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Nam Fung Kar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

2015–2015

3

Publications

3

Discovery of Vibegron: A Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Scott D. Edmondson, Cheng Zhu, Nam Fung Kar et al. · Journal of Medicinal Chemistry · 2015 · 101 citations · Full text

Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes

Ping Liu, Zhiyong Hu, Byron G. DuBois et al. · ACS Medicinal Chemistry Letters · 2015 · 13 citations · Full text

, , +18

Discovery of benzamides as potent human β3 adrenergic receptor agonists

Cheng Zhu, Nam Fung Kar, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 11 citations · Full text

, , +6

Rows per page

1–3 of 3